The Venous Thrombotic Risk in Non-Surgical Patients: Epidemiological Data and Efficacy/Safety Profile of a Low-Molecular-Weight Heparin (Enoxaparin)
- 1 January 1996
- journal article
- clinical trial
- Published by S. Karger AG in Pathophysiology of Haemostasis and Thrombosis
- Vol. 26 (Suppl. 2) , 49-56
- https://doi.org/10.1159/000217272
Abstract
In a multicentre, randomized, double-blind controlled trial comparing the low-molecular-weight heparin enoxaparin (40 mg) with a standard unfractionated heparin (Ca-heparin, 3 × 5,000 U) in deep-vein thrombosis prophylaxis in a high-risk group of 959 hospitalized medical patients, enoxaparin was at least as efficacious as standard heparin, with fewer adverse events.Keywords
This publication has 0 references indexed in Scilit: